Publications by authors named "C Meisner"

Claim this Profile
S
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.
Thomas E Mürdter, Werner Schroth, Matthew P Goetz, Roman Tremmel, Svitlana Igel, Christoph Meisner

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A systematic review of the etiopathogenesis of Kienböck's disease and a critical appraisal of its recognition as an occupational disease related to hand-arm vibration.
Stéphane Stahl, Adelana Santos Stahl, Christoph Meisner, Afshin Rahmanian-Schwarz, Hans-Eberhard Schaller

BMC Musculoskelet Disord· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
Claudia Tandler, Jonas S Heitmann, Tanja M Michel, Maddalena Marconato, Simon U Jaeger, Christoph Meisner

Int J Infect Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss.
Stefan K Plontke, Matthias Girndt, Christoph Meisner, Imma Fischer, Iris Böselt

NEJM Evid· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Jonas S Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Christoph Meisner

Nat Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis